AU2003302239A8 - Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids - Google Patents

Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids

Info

Publication number
AU2003302239A8
AU2003302239A8 AU2003302239A AU2003302239A AU2003302239A8 AU 2003302239 A8 AU2003302239 A8 AU 2003302239A8 AU 2003302239 A AU2003302239 A AU 2003302239A AU 2003302239 A AU2003302239 A AU 2003302239A AU 2003302239 A8 AU2003302239 A8 AU 2003302239A8
Authority
AU
Australia
Prior art keywords
cis
cyclic peptides
novel cyclic
aminocycloalkanecarboxylic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302239A
Other versions
AU2003302239A1 (en
Inventor
Juan R Granja Guillan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADAPTIVE THERAPEUTICS Inc
Original Assignee
ADAPTIVE THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADAPTIVE THERAPEUTICS Inc filed Critical ADAPTIVE THERAPEUTICS Inc
Publication of AU2003302239A8 publication Critical patent/AU2003302239A8/en
Publication of AU2003302239A1 publication Critical patent/AU2003302239A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
AU2003302239A 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids Abandoned AU2003302239A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US43128302P 2002-12-06 2002-12-06
US60/431,283 2002-12-06
US45943603P 2003-03-31 2003-03-31
US60/459,436 2003-03-31
US47762203P 2003-06-10 2003-06-10
US60/477,622 2003-06-10
PCT/US2003/038837 WO2004052916A2 (en) 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids

Publications (2)

Publication Number Publication Date
AU2003302239A8 true AU2003302239A8 (en) 2004-06-30
AU2003302239A1 AU2003302239A1 (en) 2004-06-30

Family

ID=32512326

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302239A Abandoned AU2003302239A1 (en) 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids

Country Status (2)

Country Link
AU (1) AU2003302239A1 (en)
WO (1) WO2004052916A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566765B2 (en) 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
CA2665559A1 (en) * 2006-10-05 2008-04-10 Lonza Ag Method for peptide synthesis
US20160031962A1 (en) * 2012-04-20 2016-02-04 Kleomenis K. Barlos Solid phase peptide synthesis of insulin using side chain achored lysine
US20180195035A1 (en) * 2014-02-12 2018-07-12 Goddard Labs, Inc. Rapid Detection of Human Pathogens in Plant Material Or Water
BR122019026066B1 (en) * 2014-12-30 2022-01-18 Dow Agrosciences Llc PICOLINAMIDE COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives

Also Published As

Publication number Publication date
WO2004052916A3 (en) 2004-09-16
WO2004052916A2 (en) 2004-06-24
AU2003302239A1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
GB0208331D0 (en) Proteins
AU2003207940A8 (en) Conformationally constrained c-backbone cyclic peptides
GB0209884D0 (en) Proteins
EP1578787A4 (en) Novel chi-conotoxin peptides (-ii)
AU2003290563A8 (en) Leptin-related peptides
EP1558628A4 (en) Antigenic peptides
GB0100196D0 (en) Peptides
AU2003228863A8 (en) Immunogenic peptides
AU2003302239A8 (en) Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
EP1487874A4 (en) Falp proteins
GB0109438D0 (en) Peptides
GB0212067D0 (en) Proteins
AU2003276846A8 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
AU2003270055A8 (en) Neurotransmission-associated proteins
GB0206684D0 (en) Novel proteins
EP1362865A4 (en) Cyclic peptide
GB0322317D0 (en) Expansin polypeptide
AU2003300785A8 (en) Carbohydrate-associated proteins
GB0219980D0 (en) Peptides
AU2002232176A1 (en) Cyclic peptide
EP1477559A4 (en) Novel polypeptide
AU2003295760A8 (en) Organelle-associated proteins
GB0216757D0 (en) Proteins
GB0214543D0 (en) Proteins
GB0213246D0 (en) Peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase